Home > Riviste > Italian Journal of Vascular and Endovascular Surgery > Fascicoli precedenti > Italian Journal of Vascular and Endovascular Surgery 2015 September;22(3) > Italian Journal of Vascular and Endovascular Surgery 2015 September;22(3):141-5

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti
Per citare questo articolo

ITALIAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Rivista di Chirurgia Vascolare ed Endovascolare


Official Journal of the Italian Society of Vascular and Endovascular Surgery
Indexed/Abstracted in: EMBASE, Emerging Sources Citation Index, Scopus


eTOC

 

REVIEWS  


Italian Journal of Vascular and Endovascular Surgery 2015 September;22(3):141-5

Copyright © 2015 EDIZIONI MINERVA MEDICA

lingua: Inglese

Treatment of acute aortic type B dissection

Gombert A. 1, Thilo Von Trotha K. 1, Jacobs M. J. 1, 2, Grommes J. 1, 3

1 European Vascular Center Aachen-Maastricht, University Hospital RWTH, Aachen, Germany; 2 European Vascular Center Aachen-Maastricht, Medical University Maastricht, The Netherlands; 3 Institute for Cardiovascular Prevention, Ludwig-Maximilians University, Munich, Germany


PDF  


Acute dissection is still a life-threatening disease. In contrast to Stanford type A aortic dissection, which needs urgent surgical repair, the majority of type B aortic dissection can be successfully treated with effective antihypertensive therapy in the acute phase. However, one- third of patients with type B aortic dissection suffer life-threatening complications, including death, rupture, increasing aortic diameter, and visceral or lower limb ischemia both in the acute and in the long-term phase. Thoracic endovascular therapy (TEVAR) has become the standard therapy in case of acute complicated type B dissection. Open surgical repair in the acute setting is only indicated in selected situations. The medical treatment remains the standard therapy for uncomplicated cases although this therapy does not prevent long-term complications like post dissection aneurysm. Little evidence derived from small prospective randomized trials support that prophylactic TEVAR in uncomplicated type B dissections might improve survival after type B dissection and reduce the risk of aneurysmatic enlargement. Therefore, there is a shift to treat more patients by endovascular means in the acute setting.

inizio pagina

Publication History

Per citare questo articolo

Gombert A, Thilo Von Trotha K, Jacobs MJ, Grommes J. Treatment of acute aortic type B dissection. Ital J Vasc Endovasc Surg 2015 September;22(3):141-5. 

Corresponding author e-mail